Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

186
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
186
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

111
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
111
Drug Delivery: Overview01:16

Drug Delivery: Overview

1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

167
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
167
Modified-Release Drug Delivery Systems: Influencing Factors01:20

Modified-Release Drug Delivery Systems: Influencing Factors

107
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
107
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

85
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay : A Target Trial Emulation.

Annals of internal medicine·2026
Same author

Respiratory surveillance through point of care molecular testing and its impacts on nursing home RSV, influenza, and SARS-CoV-2 awareness and reporting behavior: a pilot study.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Invasive E. coli Disease in US Nursing Homes: Brief Report of Case Validation Findings.

Journal of the American Geriatrics Society·2026
Same author

Burden of Invasive Escherichia coli Disease Among Veterans Residing in Community Living Centers.

Journal of the American Medical Directors Association·2025
Same author

Immunologic Evaluation of First and Second Doses of SARS-CoV-2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home Residents.

Journal of the American Geriatrics Society·2025
Same author

Barriers and Facilitators to Best Practices in Microtransitions in Care in Post-acute and Long-Term Care: A Mixed-Methods Study.

Journal of the American Medical Directors Association·2025
Same journal

Digging Deeper Into the Patient-Driven Payment Model.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Statins: The Burglar of Memory?

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Identifying Cognitive Impairment in an Older Adult Using Two Different Screening Tools.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Management of Primary Sjögren's Syndrome.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Increased Use of Medical Marijuana: Skepticism vs. Evidence.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.6K

When the Pill Box Isn't Enough

H Edward Davidson

    The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
    |May 15, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
    10:16

    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

    Published on: February 8, 2017

    8.1K
    Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
    06:27

    Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

    Published on: October 20, 2020

    5.7K

    Related Experiment Videos

    Last Updated: Mar 21, 2026

    Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
    18:57

    Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

    Published on: October 17, 2013

    47.6K
    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
    10:16

    Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

    Published on: February 8, 2017

    8.1K
    Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
    06:27

    Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

    Published on: October 20, 2020

    5.7K